A B S T R A C T Previous studies are in conflict over the effect of infusing mixed fibrinogen-fibrin degradation products on fibrinogen synthesis, as determined by changes in fibrinogen concentration or by incorporation of labeled amino acids into fibrinogen. We have injected purified homologous fragments D1 and E into rats and measured their fibrinogen and albumin synthetic rates by the [14C]carbonate technique, a method that provides quantitative estimates of hepatic secretory protein synthesis. Fibrinogen fractional synthetic rates were increased 2.5 times in animals injected with fragment D1, compared with saline-injected controls. No increases were observed in fragment E-injected animals. Neither fragment produced changes in albumin synthesis. Fragment D increased plasma fibrinogen concentration, but did not raise plasma haptoglobin levels. These results suggest that fragment D is a regulator of fibrinogen synthesis.
INTRODUCTION
Regulation of fibrinogen synthesis is complex and not well understood (1) . So far, no evidence has been obtained for feedback regulation of synthesis by plasma fibrinogen level (2) . Plasmin degradation products of fibrinogen might exercise such control, and several groups of investigators have made studies of the effect of infusing fibrinogen/fibrin degradation products on plasma fibrinogen levels. Three groups found that these products caused significant increases in plasma fibrinogen levels in dogs (3, 4) or rabbits (5), whereas two reported no change in rabbits (6, 7) . Otis and Rapaport (7) found that fibrinogen degradation products did not increase incorporation of 75Se-methionine into fibrinogen, whereas Kessler and Bell (8) reported that enhanced incorporation of this label into fibrinogen did occur after infusion of "stage two and stage three" products of fibrinogen digestion. Recently, Ittyerah et al. (9) found that degradation products derived from noncross-linked fibrin had no effect on radiolysine incorporation into fibrinogen.
The infusates used by all these workers consisted of mixtures of early (X and Y) and/or late (D1, D2, D3, and E) fibrinogen or noncross-linked fibrin products, or cross-linked fibrin degradation products (D-dimer and E); and their methods for evaluating changes in fibrinogen synthetic rates were indirect. We have injected rats with purified, homologous fragments D1 and E, and have measured their rates of fibrinogen and albumin synthesis by the [14C]carbonate method (10, 11) . We find that fragment D1, but not E, stimulates fibrinogen synthesis.
METHODS
Some of the methods have been described previously (12, 13) . Rat fibrinogen was separated from pooled heparinized rat plasma by repeated ammonium sulfate precipitation (14) . The product obtained was >95% clottable and yielded a single band without ( Fig. 1) and separate aA and ,B bands with (Fig.  2) thiol-reducing agents (15) on polyacrylamide gel electrophoresis (16) . Plasminogen was prepared by affinity chromatography (17) and activated by human urokinase (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.). Fragments D and E were isolated from fibrinogen digests by controlled plasminolysis (18) in the presence of physiologic concentrations of calcium (19) . Lysis was stopped by the addition of 0.8 M epsilon aminocaproic acid. Residual plasmin and low molecular weight peptides were removed by passage through a 2.5 x 48-cm lysine-agarose column (17) . D and E were separated by ion-exchange chromatography (20) . The final products were dialyzed against 0.15 M saline. Polyacrylamide gel electrophoresis revealed E and a D fragment with the characteristic mobility of D, (Figs. 1 and  2 ), the only D product of physiologic fibrinogenolysis (19, 21) . Four batches of fragments were used for injection into animals. Solutions (14) . Fragments D, and E were prepared by controlled plasminolysis in the presence of calcium (19) . Residual plasmin and low molecular weight peptides were removed by passage through a lysine agarose column (17) . D, was separated from E by ion-exchange chromatography (20) . Early plasmic digests in lanes 2 and 3, prepared without calcium, show traces of D2 and D3 located between the predominant D, and E bands. The amounts of protein applied were 10 ,ug for lanes 1 and 4, and 20 ,ug for lanes 2, 3, 5, and 6. isotope dilution (14) . Radioiodination of fibrinogen anid albumin was done by the IC] method of McFarlaine (22) .
Black-hooded rats of the Long-Evans strain, housed under controlled conditions of temperature and humidity, were allowed free access to food and water during the study. They were given drinking water containing 0.008 M Nal for at least 24 h before the study. Generally, eight rats were used in an experiment, one group of four receiving one of the fragments and the other group receiving saline. 2 mg of fragmnent D, 1 was determined by treating deproteinized plasma with urease. The CO2 released was measured manometrically (23) and then condensed into phenylethylamine after which its '4C radioactivity was determined by liquid scintillation counting. The specific radioactivities of urea carbon in the pooled samples were plotted against time and fitted by a single exponential function. The required specific radlioactivity, Su, was taken as that extrapolated to zero time (23) . Fu, the fraction of total urea synthesized per day, assuming steady-state conditions for urea, was taken as equal to the slope of the exponential function. After removal of aliqtuots for radioiodine counting, the remaining plasma from the 6-h samples for each four-rat group was also pooled. Fibrinogen and albumin guanidine carbon specific radioactivities and fibrinogen, albumin, and urea concentrations were determined in this final pooled sample. For measurement of guanidine carbon specific radioactivity, fibrinogen was isolated by double precipitation with ammionium sulfate and clotted with thrombin. The clot was thoroughly washed with saline. Albtumin was separated by trichloroacetic acid-ethanol precipitation (24) . Fibrin and albumini were digested in 6 N HCl for 22 h at 110°C. The acid was removed by vacuum absorption anid the arginine-6-carbon in the amino acid residues was released as CO2 by treatment with arginase and urease. Assay of CO2 was as described for uirea. The guanidine carbon specific radioactivity of fibrinogen (or albumilin) thus obtaine(d was corrected to zero time by multiplying by the fibrinogen (or albumin) plas;ma-loss correction factor. Albumiin and fibrinogen synthetic rates were determined by the method developed by Reeve et al. (10) and by McFarlane (11) . The method uises the specific radioactivity of the carbon of newly synthesized urea, after the injection of ['4C]carbonate, as a measture of the specific activity of the arginine-6-carbon entering liver-synthesized proteins. Measuremnent of this guanidine carbon specific radioactivity in the isolated proteins then allows calculation of the protein synthetic rate by McFarlane's formula (11) . The method provides results expressed as fraction of intravascular protein pool synthesized per unit time.
In other experiments, plasma concentrations of fibrinogen and haptoglobin were imeasured 16 h after intravenous or intraperitoneal injection of D or saline and compared with the known nonspecific response of these proteins to subcutaneously injected turpentine (1 ml) (25) . Haptoglobin concentrations were measured by the electrophoretic method ofJavid and Horowitz (26) , and the colorimetric method of Owen et al. (27) . Good reproducibility was obtained between these methods. Table I shows mean synthetic rates and plasma concentrations for two hepatic secretory proteins, fibrinogen and albumin. The rats treated with intraperitoneal injections of fragment D had fibrinogen synthetic rates about two-and-a-half times greater than those injected with either fragment E or saline. Plasma fibrinogen levels were also elevated in D-treated animals. There were no significant differences in albumin synthetic rates or plasma levels among the three treatment groups. Plasma volumes (mean+SE) for D-, E-, and saline-injected animals were 13.13±+ 0.73, 11.70 +0.38, and 12.09+0.67 ml. (Table I) is somewhat lower than the value of 0.662±0.036/d, it = 14, reported by Jeejeebhoy et al. (29) . Albumin fractional synithetic rates in all treatmnent grouips comnpare well with values obtained previouisly fromn this laboratory by both the ['4C]carbonate miiethod and by steady-state meiasurements with biologically screened "'3I-album-iin (12) . On the other hanid, and uinlike fragmiienit E-injected animials, the fractional synthetic rates in D-injected rats averaged about two-ancd-a-half timiies coontrol values, and plasmiia fibrinogen concentrations in D-treated animals rose significantly as well. We do not give absolute fibrinogen or albumin synthetic rates in Table I because these are derived from several variables, i.e., the product of Fp, plasma volume, and plasma fibrinogen concentration, but the observed differences are even more mlarked. Using mean values for these variables, we find an absolute fibrinogen rate in D-treated animals of 72 mg/d, nearly four times the values of 18 and 20 mg/d for E-and saline-injected rats. The effect of D on fibrinogen metabolism seems to be dose related, since 2 mg produces a significantly higher plasma concentration than does 1 mg (Table II) . The D effect does not seem to be due to a nonspecific acute phase response of fibrinogen, since D did not alter haptoglobin concentrations, in contrast to the rise in both fibrinogen and haptoglobin after turpentine. Neither does the increase appear to be associated with nonspecific effects resulting from intraperitoneal injection, since plasma levels after a single intravenous injection were even higher than after an intraperitoneal injection.
RESULTS
Some confusion has existed regarding the appropriate D fragment to test, since fibrinogeniolysis, as ordinarily carried out in vitro, produces three to five different D's (19, 30) (7) found no increased incorporation of 75Se-methionine into fibrinogen after injection of 5-min and 2-h fibrinogen lysates into rabbits. These differences are diffictult to reconcile. There may be a close effect since Bocci et al. (31) noted that small doses of fragment D were more effective in raising plasma fibrinogen levels than doses one hun-dredl times higher. We estimiiate from their data that the smiiallest effective dose used by Bocci et Lipinski and Gurewich (33) have questioned whether fibrinogen (unlike fibrin) degradation products even occur in vivo except with thrombolytic therapy. However, Mersky et al. (34) have recently provided valuable information on this point. These investigators isolated fibrinogen-related antigen from human plasma by immunoaffinity chromatography. Starting with 2 ml or less of plasma from defibrinating patients, they found sufficient fibrinogen-related proteins to demonstrate by polyacrylamide gel electrophoresis the existence of components with electrophoretic mobilities the same as fibrinogen fragments X, Y, and D, as well as fibrin fragment D-dimer. It seems likely that lesser amounts of these fragments are present in less acute disorders associated with coagulation disturbances.
The failure of fragment E to increase fibrinogen production is of interest. Bocci et al. (31) , examining the effect of 1-204 mg of fragment E on plasma fibrinogen levels in rabbits, found the lowest effective dose to be 20.4 mg (equivalent to lysis of >30% of plasma fibrinogen). They concluded that fragment D is at least ten times as effective as E as a stimulus. We found that 1 mg of E, equivalent to lysis of 16% of our animals' plasma fibrinogen, did not increase fibrinogen production. It is possible that higher doses of E might have an effect, but our data suggest that in the rat, as in the rabbit, E is not as effective a stimulator of fibrinogen synthesis as fragment D,. 
